Effects of transforming growth factor β-1 on growth-regulatory genes in tumour-derived human oral keratinocytes

I. C. Paterson, V. Patel, J. R. Sandy, S. S. Prime, William Andrew Yeudall

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

This study examined the effect of transforming growth factor β-1 (TGF-β 1) on c-myc, RB1, junB and p53 expression together with pRb phosphorylation, in carcinoma-derived and normal human oral keratinocytes with a range of inhibitory responses to this ligand. Amplification of c-myc was observed in eight of eight tumour-derived cell lines and resulted in corresponding mRNA expression. The down-regulation of c-myc expression by TGF-β1 predominantly reflected growth inhibition by TGF-β1, but in two of eight tumour-derived cell lines which were partially responsive to TGF-β1 c-myc expression was unaltered by this ligand. While RB1 mRNA levels were unaltered by TGF-β1, the ligand caused the accumulation of the underphosphorylated form of the Rb protein in all cells irrespective of TGF-β1-induced growth arrest. junB expression was up-regulated by TGF-β1 in cells with a range of growth inhibitory responses. All cells contained mutant p53. TGF-β1 did not affect p53 mRNA expression in both tumour-derived and normal keratinocytes and there was no alteration in p53 protein levels in keratinocytes expressing stable p53 protein following TGF-β1 treatment. The data indicate that TGF-β-induced growth control can exist independently of the presence of mutant p53 and the control of Rb phosphorylation and c-myc down-regulation. It may be that TGF-β growth inhibition occurs via multiple mechanisms and that the loss of one pathway during tumour progression does not necessarily result in the abrogation of TGF-β-induced growth control.

Original languageEnglish (US)
Pages (from-to)922-927
Number of pages6
JournalBritish Journal of Cancer
Volume72
Issue number4
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Transforming Growth Factors
Regulator Genes
Keratinocytes
Growth
Neoplasms
Ligands
Tumor Cell Line
Messenger RNA
Down-Regulation
Phosphorylation
Retinoblastoma Protein
Proteins
Carcinoma

Keywords

  • C-myc
  • Junb
  • Keratinocytes
  • P53
  • Rb phosphorylation
  • Transforming growth factor β

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Effects of transforming growth factor β-1 on growth-regulatory genes in tumour-derived human oral keratinocytes. / Paterson, I. C.; Patel, V.; Sandy, J. R.; Prime, S. S.; Yeudall, William Andrew.

In: British Journal of Cancer, Vol. 72, No. 4, 01.01.1995, p. 922-927.

Research output: Contribution to journalArticle

@article{ae2eff0e748746d5b22f6acf5d481a23,
title = "Effects of transforming growth factor β-1 on growth-regulatory genes in tumour-derived human oral keratinocytes",
abstract = "This study examined the effect of transforming growth factor β-1 (TGF-β 1) on c-myc, RB1, junB and p53 expression together with pRb phosphorylation, in carcinoma-derived and normal human oral keratinocytes with a range of inhibitory responses to this ligand. Amplification of c-myc was observed in eight of eight tumour-derived cell lines and resulted in corresponding mRNA expression. The down-regulation of c-myc expression by TGF-β1 predominantly reflected growth inhibition by TGF-β1, but in two of eight tumour-derived cell lines which were partially responsive to TGF-β1 c-myc expression was unaltered by this ligand. While RB1 mRNA levels were unaltered by TGF-β1, the ligand caused the accumulation of the underphosphorylated form of the Rb protein in all cells irrespective of TGF-β1-induced growth arrest. junB expression was up-regulated by TGF-β1 in cells with a range of growth inhibitory responses. All cells contained mutant p53. TGF-β1 did not affect p53 mRNA expression in both tumour-derived and normal keratinocytes and there was no alteration in p53 protein levels in keratinocytes expressing stable p53 protein following TGF-β1 treatment. The data indicate that TGF-β-induced growth control can exist independently of the presence of mutant p53 and the control of Rb phosphorylation and c-myc down-regulation. It may be that TGF-β growth inhibition occurs via multiple mechanisms and that the loss of one pathway during tumour progression does not necessarily result in the abrogation of TGF-β-induced growth control.",
keywords = "C-myc, Junb, Keratinocytes, P53, Rb phosphorylation, Transforming growth factor β",
author = "Paterson, {I. C.} and V. Patel and Sandy, {J. R.} and Prime, {S. S.} and Yeudall, {William Andrew}",
year = "1995",
month = "1",
day = "1",
doi = "10.1038/bjc.1995.434",
language = "English (US)",
volume = "72",
pages = "922--927",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Effects of transforming growth factor β-1 on growth-regulatory genes in tumour-derived human oral keratinocytes

AU - Paterson, I. C.

AU - Patel, V.

AU - Sandy, J. R.

AU - Prime, S. S.

AU - Yeudall, William Andrew

PY - 1995/1/1

Y1 - 1995/1/1

N2 - This study examined the effect of transforming growth factor β-1 (TGF-β 1) on c-myc, RB1, junB and p53 expression together with pRb phosphorylation, in carcinoma-derived and normal human oral keratinocytes with a range of inhibitory responses to this ligand. Amplification of c-myc was observed in eight of eight tumour-derived cell lines and resulted in corresponding mRNA expression. The down-regulation of c-myc expression by TGF-β1 predominantly reflected growth inhibition by TGF-β1, but in two of eight tumour-derived cell lines which were partially responsive to TGF-β1 c-myc expression was unaltered by this ligand. While RB1 mRNA levels were unaltered by TGF-β1, the ligand caused the accumulation of the underphosphorylated form of the Rb protein in all cells irrespective of TGF-β1-induced growth arrest. junB expression was up-regulated by TGF-β1 in cells with a range of growth inhibitory responses. All cells contained mutant p53. TGF-β1 did not affect p53 mRNA expression in both tumour-derived and normal keratinocytes and there was no alteration in p53 protein levels in keratinocytes expressing stable p53 protein following TGF-β1 treatment. The data indicate that TGF-β-induced growth control can exist independently of the presence of mutant p53 and the control of Rb phosphorylation and c-myc down-regulation. It may be that TGF-β growth inhibition occurs via multiple mechanisms and that the loss of one pathway during tumour progression does not necessarily result in the abrogation of TGF-β-induced growth control.

AB - This study examined the effect of transforming growth factor β-1 (TGF-β 1) on c-myc, RB1, junB and p53 expression together with pRb phosphorylation, in carcinoma-derived and normal human oral keratinocytes with a range of inhibitory responses to this ligand. Amplification of c-myc was observed in eight of eight tumour-derived cell lines and resulted in corresponding mRNA expression. The down-regulation of c-myc expression by TGF-β1 predominantly reflected growth inhibition by TGF-β1, but in two of eight tumour-derived cell lines which were partially responsive to TGF-β1 c-myc expression was unaltered by this ligand. While RB1 mRNA levels were unaltered by TGF-β1, the ligand caused the accumulation of the underphosphorylated form of the Rb protein in all cells irrespective of TGF-β1-induced growth arrest. junB expression was up-regulated by TGF-β1 in cells with a range of growth inhibitory responses. All cells contained mutant p53. TGF-β1 did not affect p53 mRNA expression in both tumour-derived and normal keratinocytes and there was no alteration in p53 protein levels in keratinocytes expressing stable p53 protein following TGF-β1 treatment. The data indicate that TGF-β-induced growth control can exist independently of the presence of mutant p53 and the control of Rb phosphorylation and c-myc down-regulation. It may be that TGF-β growth inhibition occurs via multiple mechanisms and that the loss of one pathway during tumour progression does not necessarily result in the abrogation of TGF-β-induced growth control.

KW - C-myc

KW - Junb

KW - Keratinocytes

KW - P53

KW - Rb phosphorylation

KW - Transforming growth factor β

UR - http://www.scopus.com/inward/record.url?scp=0028871322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028871322&partnerID=8YFLogxK

U2 - 10.1038/bjc.1995.434

DO - 10.1038/bjc.1995.434

M3 - Article

VL - 72

SP - 922

EP - 927

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -